Notice of Registration - 2010
[Federal Register: November 12, 2010 (Volume 75, Number 218)]
[Notices]
[Page 69467]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12no10-92]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 17, 2010, and published in the Federal
Register on June 28, 2010, (75 FR 36683), Wildlife Laboratories, Inc.,
1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Carfentanil (9743), a basic
class of controlled substance listed in schedule II.
The company will manufacture the above listed controlled substance
for sale to veterinary pharmacies, zoos, and for other animal and
wildlife applications.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Wildlife Laboratories, Inc. to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Wildlife Laboratories, Inc. to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic class of controlled substance listed.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-28522 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
